Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...
Hyderabad: A Hyderabad-based biotech start-up, Utopia Therapeutics, has secured a United States patent for its pioneering immunotherapy-based obesity vaccine, marking a significant milestone ...
BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...
Over the past years, I have closely followed the evolution of the global oncology industry. What I have observed is steady, structural growth supported by science, policy support, and increasing ...
ANK-203 is a first-in-class anchored immunotherapy designed to unlock the full therapeutic potential of monoclonal antibody CD137 through localized delivery and retentionIn preclinical studies, ...
Obesity and related metabolic disorders such as fatty liver disease and high triglycerides are rising globally, with limited long-term treatment options ...
The cancer vaccine market presents opportunities in personalized and therapeutic vaccines, innovations in delivery strategies, and combination therapies. Collaborations and licensing by key players ...
Monoclonal antibodies offer key opportunities in precision immunotherapy for cancer and chronic diseases. Focus areas include targeted novel therapies, stereo-specific antibodies for enhanced efficacy ...
The FDA accepted the new drug application for iberdomide based on minimal residual disease negativity benefit shown in the ...
Adagene Inc. ('Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel ...
Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.
HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results